Diabetes Care:母体血脂影响胎儿生长发育

2013-06-27 Diabetes Care dxy

为了研究母体血液循环中“燃料”与新生儿大小间的关系,并比较血糖和脂质的相对影响。来自印度浦那爱德华国王纪念医院研究中心Kamalnayan Bajaj 糖尿病学研究中心的Kulkarni等进行了一项研究,研究发现,除了已经明确的血糖对新生儿的影响,母体脂质对新生儿大小也有一定的影响。研究结果在线发表于2013年6月11日美国的《糖尿病治疗》(Diabetes Care)杂志上。 浦那母体营养研究

为了研究母体血液循环中“燃料”与新生儿大小间的关系,并比较血糖和脂质的相对影响。来自印度浦那爱德华国王纪念医院研究中心Kamalnayan Bajaj 糖尿病学研究中心的Kulkarni等进行了一项研究,研究发现,除了已经明确的血糖对新生儿的影响,母体脂质对新生儿大小也有一定的影响。研究结果在线发表于2013年6月11日美国的《糖尿病治疗》(Diabetes Care)杂志上。

浦那母体营养研究(1993-1996)旨在调查母体营养对胎儿生长发育的影响。研究人员测定妊娠期母亲体形、血糖和脂质浓度,采用相关性和回归分析方法评价它们与足月新生儿大小的关系。

结果显示,参加研究的母亲(n=631)较年轻(平均年龄21岁),身材矮小(平均身高151.9cm),偏瘦(BMI 18.0kg/m2),但是脂肪相对较多(身体脂肪21.1%)。她们的饮食主要以素食为主。妊娠18和28周,空腹血糖浓度仍较稳定,而总胆固醇和甘油三酯水平升高,HDL-胆固醇水平降低。胎儿平均出生体重为2666 g。妊娠18和28周时,总胆固醇和甘油三酯水平均与新生儿大小直接相关,而血糖水平仅在妊娠28周时与新生儿大小直接相关。妊娠28周时,母体空腹血糖、胆固醇和甘油三酯每升高1个SD值,胎儿出生体重分别增加37g,54g和36g(P值均<0.05)。HDL-胆固醇水平与新生儿测定结果没有相关性。在结果分析中(n=700),即使加入早产的孕妇,得到的结果也相似。

研究表明,除了已经明确的血糖对新生儿的影响,母体脂质对新生儿大小也有一定的影响。作者建议,进一步的研究应该直接确定这些研究发现的临床相关性。

Maternal Lipids Are as Important as Glucose for Fetal Growth: Findings from the Pune Maternal Nutrition Study.
Abstract
OBJECTIVETo study the relationship between maternal circulating fuels and neonatal size and compare the relative effects of glucose and lipids.RESEARCH DESIGN AND METHODSThe Pune Maternal Nutrition Study (1993-1996) investigated the influence of maternal nutrition on fetal growth. We measured maternal body size and glucose and lipid concentrations during pregnancy and examined their relationship with birth size in full-term babies using correlation and regression techniques.RESULTSThe mothers (n = 631) were young (mean age 21 years), short (mean height 151.9 cm), and thin (BMI 18.0 kg/m2) but were relatively more adipose (body fat 21.1%). Their diet was mostly vegetarian. Between 18 and 28 weeks' gestation, fasting glucose concentrations remained stable, whereas total cholesterol and triglyceride concentrations increased and HDL-cholesterol concentrations decreased. The mean birth weight of the offspring was 2666 g. Total cholesterol and triglycerides at both 18 and 28 weeks and plasma glucose only at 28 weeks were associated directly with birth size. One SD higher maternal fasting glucose, cholesterol, and triglyceride concentrations at 28 weeks were associated with 37, 54, and 36 g higher birth weights, respectively (P < 0.05 for all). HDL-cholesterol concentrations were unrelated to newborn measurements. The results were similar if preterm deliveries also were included in the analysis (total n = 700).CONCLUSIONSOur results suggest an influence of maternal lipids on neonatal size in addition to the well-established effect of glucose. Further research should be directed at defining the clinical relevance of these findings.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1945773, encodeId=ec781945e7359, content=<a href='/topic/show?id=49ce6961069' target=_blank style='color:#2F92EE;'>#生长发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69610, encryptionId=49ce6961069, topicName=生长发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35a460, createdName=fengyi812, createdTime=Wed Apr 02 02:21:00 CST 2014, time=2014-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901118, encodeId=2c2b1901118d4, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Thu Jan 30 20:21:00 CST 2014, time=2014-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759315, encodeId=90371e59315b1, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Dec 29 15:21:00 CST 2013, time=2013-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636706, encodeId=fbf01636e06bb, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Fri May 02 07:21:00 CST 2014, time=2014-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346993, encodeId=b8071346993f8, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Sat Jun 29 07:21:00 CST 2013, time=2013-06-29, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1945773, encodeId=ec781945e7359, content=<a href='/topic/show?id=49ce6961069' target=_blank style='color:#2F92EE;'>#生长发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69610, encryptionId=49ce6961069, topicName=生长发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35a460, createdName=fengyi812, createdTime=Wed Apr 02 02:21:00 CST 2014, time=2014-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901118, encodeId=2c2b1901118d4, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Thu Jan 30 20:21:00 CST 2014, time=2014-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759315, encodeId=90371e59315b1, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Dec 29 15:21:00 CST 2013, time=2013-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636706, encodeId=fbf01636e06bb, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Fri May 02 07:21:00 CST 2014, time=2014-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346993, encodeId=b8071346993f8, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Sat Jun 29 07:21:00 CST 2013, time=2013-06-29, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1945773, encodeId=ec781945e7359, content=<a href='/topic/show?id=49ce6961069' target=_blank style='color:#2F92EE;'>#生长发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69610, encryptionId=49ce6961069, topicName=生长发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35a460, createdName=fengyi812, createdTime=Wed Apr 02 02:21:00 CST 2014, time=2014-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901118, encodeId=2c2b1901118d4, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Thu Jan 30 20:21:00 CST 2014, time=2014-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759315, encodeId=90371e59315b1, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Dec 29 15:21:00 CST 2013, time=2013-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636706, encodeId=fbf01636e06bb, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Fri May 02 07:21:00 CST 2014, time=2014-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346993, encodeId=b8071346993f8, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Sat Jun 29 07:21:00 CST 2013, time=2013-06-29, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1945773, encodeId=ec781945e7359, content=<a href='/topic/show?id=49ce6961069' target=_blank style='color:#2F92EE;'>#生长发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69610, encryptionId=49ce6961069, topicName=生长发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35a460, createdName=fengyi812, createdTime=Wed Apr 02 02:21:00 CST 2014, time=2014-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901118, encodeId=2c2b1901118d4, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Thu Jan 30 20:21:00 CST 2014, time=2014-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759315, encodeId=90371e59315b1, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Dec 29 15:21:00 CST 2013, time=2013-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636706, encodeId=fbf01636e06bb, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Fri May 02 07:21:00 CST 2014, time=2014-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346993, encodeId=b8071346993f8, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Sat Jun 29 07:21:00 CST 2013, time=2013-06-29, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1945773, encodeId=ec781945e7359, content=<a href='/topic/show?id=49ce6961069' target=_blank style='color:#2F92EE;'>#生长发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69610, encryptionId=49ce6961069, topicName=生长发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35a460, createdName=fengyi812, createdTime=Wed Apr 02 02:21:00 CST 2014, time=2014-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901118, encodeId=2c2b1901118d4, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Thu Jan 30 20:21:00 CST 2014, time=2014-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759315, encodeId=90371e59315b1, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Dec 29 15:21:00 CST 2013, time=2013-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636706, encodeId=fbf01636e06bb, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Fri May 02 07:21:00 CST 2014, time=2014-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346993, encodeId=b8071346993f8, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Sat Jun 29 07:21:00 CST 2013, time=2013-06-29, status=1, ipAttribution=)]
    2013-06-29 neurowu

相关资讯

抗抑郁药或与心血管病炎性标志物较高有关

  6月13日在线发表于《美国公共卫生杂志》(Am J Public Health)的一项新流行病学研究表明,抑郁症状和应用抗抑郁药与糖尿病和心血管疾病(CVD)风险相关的标志物具有相关性。   这项研究纳入了“女性健康倡议”(WHI)中超过2000名的绝经后女性受试者,研究显示,与健康受试者相比,那些抑郁症状较严重并且应用了抗抑郁药物的患者炎性生物标志物C—反应蛋

英研究显示糖尿病致死概率大幅降低

  据英国广播公司6月20日报道,调查研究显示,自20世纪90年代以来,糖尿病患者的死亡风险大幅下降。专家猜测,这可能与良好的治疗有关。   《糖尿病学》(Diabetologia)杂志发布了这项研究成果。研究表明,上世纪90年代,糖尿病患者在一定时期内死亡的可能性几乎是非糖尿病患者的两倍。到2009年,这一风险显著下降,大约为1.5倍。   在1996年至2009年间,研究人员对大约1000

Stroke:国内脑动脉粥样硬化存在地理分布差异和性别差异

我国脑缺血患者动脉粥样硬化的地理分布差异和性别差异尚未清楚阐述。为此,我国北京天坛医院的王拥军教授和香港中文大学威尔斯王子医院药物与治疗科的Xinying Zou博士等人进行合作,完成了一项研究,研究结果在线发表在2013年6月11日的Stroke杂志上。研究结果显示:我国的症状性脑动脉粥样硬化存在地理分布差异和性别差异。 该研究是一项前瞻性多中心研究。研究人员评估了国内22所医院的2864位连

沙格列汀:得糖尿病之陇难望心血管病之蜀

一项名为SAVOR试验的大规模的临床研究显示,阿斯利康和百时美施贵宝的糖尿病药物沙格列汀(Onglyza)不能降低患者的心血管病风险。这使得那些曾认为这款药物可能会超过竞争产品的投资人士感到失望。尽管沙格列汀是第一款被证明具备心血管安全特性的口服降糖药,但这一临床试验表明,期待沙格列汀能将糖尿病与心血管病双双拿下的希望破灭了。 阿斯利康和百时美施贵宝共同销售几款糖尿病药物,6月18日他们表示,这

JAMA Intern Med:红肉摄入量增多 2型糖尿病风险增加?

  美国和加拿大联合研究表明,红肉摄入量增多与随后2型糖尿病(T2DM)风险增加相关,且这一相关性受到体重影响。限制红肉摄入量有利于预防T2DM。论文6月17日在线发表于《美国医学会杂志·内科学》(JAMA Intern Med)。   该研究随访近15万人。使用食物频率问卷评估饮食情况,并每4年评估一次。校正年龄、家族史、种族、婚姻状况,初始红肉摄入量、吸烟状态、其他生活方

ADA 2013:胰岛移植可恢复葡萄糖反调节

  芝加哥——一项小型单中心研究显示,对于长期罹患1型糖尿病的患者,肝内胰岛移植可恢复葡萄糖反调节和改善低血糖症状。宾夕法尼亚大学医院内科的Michael R. Rickels医生在美国糖尿病学会(ADA)2013年会上报告称,上述结果支持考虑对未察觉的严重低血糖患者采取这种手术。   目前,学者们正在评估能否将胰岛移植作为严重低血糖1型糖尿病患者的治疗手段。“随着1型糖尿病病程的延长,低血糖的